Physical Activity & Education for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how physical activity (PA) can enhance health for people with obesity, without emphasizing weight loss. The researchers aim to understand how enjoyable and accessible exercises can overcome barriers like stigma and poor fitness, benefiting heart health and metabolism. Participants will be divided into two groups: one will follow a new PA program called the PATH Intervention, and the other will serve as a control group. Suitable candidates are adults with a BMI over 30 who currently engage in less than 150 minutes of moderate activity per week.
As an unphased trial, this study provides a unique opportunity to contribute to understanding how physical activity can improve health beyond weight loss.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the PATH intervention is safe for individuals with obesity?
Research has shown that the PATH program effectively helps people with obesity overcome barriers to physical activity. Although specific safety details about this program aren't highlighted in available sources, the PATH program emphasizes physical activity, which is generally safe for most people when performed correctly.
The program is inclusive, offering fun and easily accessible activities to reduce stigma and improve fitness without focusing solely on weight loss. This emphasis on enjoyment and accessibility can make participants more comfortable.
Since the PATH program doesn't involve new drugs or medical devices, it carries a lower risk of side effects compared to treatments that do. However, as with any exercise program, participants should consult their healthcare providers to ensure the activities suit their health needs.12345Why are researchers excited about this trial?
Unlike traditional obesity treatments that often rely on medication or surgery, the PATH Intervention is unique because it focuses on incorporating physical activity and education. Researchers are excited about this approach because it empowers individuals to adopt healthier lifestyles through tailored exercise plans and educational support, potentially leading to sustainable weight loss and improved overall health. This method emphasizes behavior change and personal empowerment, which could offer a more holistic and long-term solution compared to conventional treatments.
What evidence suggests that the PATH intervention could be effective for obesity?
Studies have shown that physical activity (PA) can greatly improve overall health, even without weight loss. Research indicates that being active lowers the risk of heart disease and diabetes, common conditions in people with obesity. Programs focusing on fun and easy activities tend to attract and retain more participants. In this trial, participants may be assigned to the PATH intervention, which aims to boost fitness and well-being by addressing challenges like stigma and low self-confidence. This method encourages better health, especially in diverse groups, by promoting regular physical activity as a lifestyle change rather than focusing solely on weight loss.678910
Who Is on the Research Team?
Jacob Kariuki, PhD, NP
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for adults over 18 with obesity (BMI ≥30kg/m2) who don't meet physical activity guidelines and have regular internet access. It's not for pregnant individuals, those in health-related litigation, or people needing supervised exercise due to conditions like stroke or diabetes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the PATH intervention, which includes walking, dance, and abdominal core workouts
Follow-up
Participants are monitored for changes in adipocytokines and other health markers
What Are the Treatments Tested in This Trial?
Interventions
- PATH Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
American Diabetes Association
Collaborator
Georgia Center for Diabetes Translation Research
Collaborator